Epidemiology and prognostic factors of candidemia in cancer patients

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Tang, Hung Jen ^a,b   Liu, Wei Lun ^a   Lin, Hsin Lan ^a   Lai, Chih Cheng ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; MICAFUNGIN;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CANCER PATIENT; CANCER SURVIVAL; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CENTRAL VENOUS CATHETER; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CONCURRENT INFECTION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HEAD AND NECK CANCER; HEALTHCARE ASSOCIATED INFECTION; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PROGNOSIS; RETROSPECTIVE STUDY; STAPHYLOCOCCUS; CANDIDIASIS; COMPLICATION; HOSPITAL; ISOLATION AND PURIFICATION; MIDDLE AGED; NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BACTEREMIA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; FEMALE; HOSPITAL MORTALITY; HOSPITALS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES;

EID: 84902491106     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099103     Document Type: Article

References (27)

1. Montagna MT, Caggiano G, Lovero G, De Giglio O, Coretti C, et al. (2013) Epidemiology of invasive fungal infections in the intensive care unit: results of multicenter Italian survey (AURORA PROJECT). Infection 41; 645-53.
2. Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M (2012) The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis 73: 45-8.
3. Ruan SY, Hsueh PR (2009) Invasive candidiasis: an overview from Taiwan. J Formos Med Assoc 108: 443-51.
4. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, et al (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39: 309-17. (Pubitemid 39050477)
5. Hsueh PR, Teng LJ, Yang PC, Ho SW, Luh KT (2002) Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole. Microb Drug Resist 8: 311-9.
6. Lai CC, Chu CC, Wang CY, Tsai HY, Cheng A, et al. (2012) Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan. Int J Antimicrob Agents 40: 349-53.
7. Lai CC, Tan CK, Huang YT, Shao PL, Hsueh PR (2008) Current challenges in the management of invasive fungal infections. J Infect Chemother 14: 77-85.
8. Schuster MG, Meibohm A, LIoyd L, Strom B (2013) Risk factors and outcomes of Candida krusei bloodstream infection: a matched, case-control study. J Infect 66: 278-84.
9. Tragiannidis A, Fegeler W, Rellensmann G, Debus V, Muller V, et al. (2012) Candidemia in a European paediatric university hospital: a 10-year observational study. Clin Microbiol Infect 18: E27-30.
10. Ortega M, Marco F, Soriano A, Almela M, Martinez JA, et al. (2011) Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008. J Hosp Infect 77: 157-61.
11. Munoz P, Giannela M, Fanciulli C, Guinea J, Valerio M, et al. (2011) Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital. Clin Microbiol Infect 17: 1538-45.
12. Mor M, Gilad G, Kornreich L, Fisher S, Yaniv I, et al. (2011) Invasive fungal infections in pediatric oncology. Pediatr Blood Cancer 56: 1092-7.
13. Velasco E, Bigni R (2008) A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia. Eur J Clin Microbiol Infect Dis 7: 1071-8.
14. Lewis RE, Cahame-Zuniga L, Leventakos K, Chamilos G, Ben-Ami R, et al. (2013) Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses 56: 638-45.
15. Sipasas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, et al. (2009) Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115: 4745-52.
16. Megalakaki C, Perlorentzou S, Dadakaridou M, Dima I, Repousis P, et al. (2006) Candidemia in patients with acute leukemia. J BUON 11: 191-5. (Pubitemid 44755700)
17. Zirekel J, Klinker H, Kuhn A, Abele-Horn M, Tappe D, et al. (2012) Epidemiology of Candida bloodstream infections in patients with hematological malignancies or solid tumors. Med Mycol 50: 50-5.
18. Li D, Zhang W, Zheng S, Ma Z, Zhang P, et al. (2013) Surveillance study of candidemia in cancer patients in North China. Med Mycol 51: 378-84.
19. Slavin MA, Sorrell TC, Marriott D, Thursky KA, Nguyen Q, et al. (2010) Candidaemia in adult cancer patients: risk for fluconazole-resistant isolates and death. J Antimicrob Chemother 65: 1042-51.
20. Sabino R, Verissimo C, Brandao J, Alves C, Parada H, et al. (2010) Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospital. Med Mycol 48: 346-51.
21. Bergamasco MD, Garnica M, Colombo AL, Nucci M (2013) Epidemiology of candidemia in patients with hematologic malignancies and solid tumors in Brazil. Mycoses 56: 256-63.
22. Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I (2008) The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 112: 2493-9.
23. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection in the acute care setting. Am J Infect Control 36: 309-32. (Pubitemid 351763841)
24. Chen YC, Chang SC, Luh KT, Hsieh WC (2003) Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J Antimicrob Chemother 52: 71-7.
25. Cheng MF, Yu KW, Tang RB, Fan YH, Yang YL, et al. (2004) Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis 48: 33-7.
26. Lu JJ, Lee SY, Chiueh TS (2004) In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method. J Microbiol Immunol Infect 37: 335-42.
27. Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, et al TSARY Hospitals. (2008) Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Diagn Microbiol Infect Dis 61: 175-80.